Hospitals, health systems, and providers having one of the most difficult financial years on record

Article

Declining volume and revenue with increasing expenses mean many systems are ending the year in the red.

Hospitals, health systems, and physician practices all had an unfavorable mix of volume, revenue, and expensed that continued through the third quarter, marking a year-long trend of negative margins, according to data from Kaufman Hall.

“Health systems are starting to get a clear picture of what service lines have a positive effect on their margins and which ones are weighing them down,” said Matthew Bates, managing director and Physician Enterprise service line lead with Kaufman Hall, in a statement. “Without a positive margin there is no mission. Health systems must think carefully and strategically about what areas of care they invest in for the future.”

The median year-to-date operating margin index for hospitals was -0.1% in September, for a ninth straight month of negative actual operating margins, according to findings in the latest National Hospital Flash Report.

According to the latest Physician Flash Report, the median investment/subsidy per provider full-time equivalent (FTE) reached $227,282 in Q3 2022, slightly up from the second quarter and returning physician practices to a trend of increasing investments/subsidies after a temporary decrease in Q2. Investment/subsidies remain well above where they were at this time last year, with Q3 2021 median investment/subsidies per provider FTE of $190,608.

The average patient length of stay remained steady from last month, with adjusted patient days and emergency department visits both dropping 3% from August. Operating room minutes decreased 5% from last month, hurting hospital revenues. Adjusted discharges were also down 3%, with a slight increase (1%) in observation days driving the drop in discharges. In total, discharges were down 3% from August.

Physician practice volumes increased in Q3, but not enough to outpace expenses. Net patient revenue per provider FTE increased slightly from Q2 to Q3 2022, reaching $389,017 in Q3, driven by increases in net patient revenues in medical specialties and primary care. Expenses outweighed volume and revenue increases, however, with total direct expense per provider at $626,120, up slightly from Q2 and up 9% from Q3 2021.

Hospital total expenses dropped slightly in September, down 1% from August, but are up 3% from September 2021 and are up 8%

“Heading into the final quarter of the year, hospitals and physician practices have had little reprieve during a very difficult 2022 from a financial perspective,” said Erik Swanson, a senior vice president of Data and Analytics with Kaufman Hall, in a statement. “Hospitals and physician practices could climb back into the black by the end of the year, but it is looking less and less likely as months of negative margins continue to pile up.”

The National Hospital Flash Report draws on data from more than 900 hospitals from Syntellis Performance Solutions. The Physician Flash Report draws on data based on more than 200,000 providers, also from Syntellis.

This article originally appeared on Medical Economics®.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.